Sagility India | Business Upturn

Sagility India shares hit 5% upper circuit as net profit surges nearly 3x to Rs 216.9 crore

Aditya Bhagchandani — Thu, 06 Feb 2025 03:52:01 +0000

Shares of Sagility India Ltd hit the 5% upper circuit at ₹52.73 following the company’s stellar Q3 FY25 performance, which saw a 207.2% YoY increase in net profit driven by revenue growth and operational efficiency.

Stock Performance Update (as of 9:20 AM)

Current share price: ₹52.73 (+5%)
Previous close: ₹50.22
Market cap: ₹246.33 billion
52-week range: ₹27.02 – ₹56.40

Key Financial Highlights (Q3 FY25)

Net profit: ₹216.9 crore, up 207.2% YoY from ₹70.6 crore in Q3 FY24.
Revenue from operations: ₹1,453 crore, a 15.3% YoY increase from ₹1,260 crore.
EBITDA: ₹391.8 crore, up 50.7% YoY from ₹260 crore.
EBITDA margin: Expanded to 27% from 20.6% YoY.
Basic EPS: ₹0.46, reflecting 181.4% YoY growth.
Adjusted basic EPS: ₹0.56, up 53.5% YoY.

Business Expansion and Developments

Sagility strengthened its position in the healthtech market with the successful acquisition of BroadPath Healthcare Solutions on January 29, 2025, gaining access to a large national payor and 30 mid-market payor clients. As of Q3 FY25, the company had 39,595 employees and maintained operations across five countries with 32 delivery centres.

9M FY25 Performance Highlights (April-December 2024)

Total revenue: ₹4,001.4 crore, up 15.3% YoY.
Adjusted EBITDA: ₹1,110.4 crore, up 30.2% YoY, representing 27.8% of revenue.
Adjusted PAT: ₹570.9 crore, up 34.5% YoY.
Basic EPS: ₹0.78, reflecting a 124.6% YoY increase.
Operating cash flow to EBITDA ratio: 94%.

Disclaimer:
The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Business Upturn is not liable for any losses arising from the use of this information.

Sagility India shares hit 5% upper circuit after arm acquires BroadPath Healthcare Solutions for Rs 502 crore

Aman Shukla — Thu, 30 Jan 2025 04:54:37 +0000

Sagility India shares hit a 5% upper circuit after its step-down subsidiary, Sagility LLC, announced the acquisition of BroadPath Healthcare Solutions for Rs 502 crore. This acquisition marks a transformative move for Sagility, enhancing its position in the healthcare sector.

By acquiring BroadPath, Sagility solidifies its presence in the U.S. payer market, gaining access to six of the top 10 U.S. payers. This strategic acquisition also diversifies Sagility’s client base, adding over 30 mid-market clients, including payers, third-party administrators, and healthcare providers, expanding the company’s revenue potential.

The move also strengthens Sagility’s capabilities in member acquisition and enrollment services, particularly within Medicare and Medicaid, aligning with its multi-shore delivery model to offer enhanced value to clients. Additionally, BroadPath’s work-from-home platform, Bhive, contributes to operational efficiencies, optimizing employee engagement and productivity—key benefits in today’s remote work environment.

Financially, the acquisition is expected to be accretive to earnings per share (EPS) from day one, with BroadPath generating approximately US$ 70M in revenue.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.

Sagility India shares surge 15% in 2 days after strong Q2 results

Aman Shukla — Wed, 27 Nov 2024 04:26:54 +0000

Sagility India saw its shares surge 15% in just two days after reporting an impressive 236% YoY rise in Q2FY25 adjusted profit after tax (PAT). The company, a leading provider of technology-driven solutions for the US healthcare sector, posted a PAT of ₹117.34 crore, up from ₹34.96 crore in Q2FY24.

The company also reported a 21% increase in revenue, reaching ₹1,325 crore compared to ₹1,094.10 crore last year. EBITDA for the quarter rose 20.3% YoY to ₹316.5 crore, with a slight dip in EBITDA margin to 23.9% from 24.1% in the previous year.

Today, as of 9:55 am, Sagility India shares were trading 2.89% higher at Rs 32.45 on the NSE.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.

Sagility India IPO: Shares lists at 3.53% premium on NSE at ₹31.06 per share

Aditya Bhagchandani — Tue, 12 Nov 2024 04:29:48 +0000

Sagility India Limited’s IPO opened for trading today, debuting with a slight premium. The issue price was set at ₹30.00 per share, and the stock listed at ₹31.06 on both the NSE and BSE, reflecting a 3.53% increase.

The IPO, which raised ₹2,106.60 crore through a 100% offer-for-sale (OFS) of 70.22 crore equity shares, saw solid demand. Sagility India has demonstrated promising financial growth, with revenue up 9.6% YoY to ₹1,223 crore in Q1 FY25 and a 12.69% increase to ₹4,753 crore in FY24.

Investors who received shares in the allotment may consider holding for potential medium-term growth as the company capitalizes on its strong performance.

Disclaimer: This information is provided for informational purposes only and does not constitute financial advice. Please consult a financial advisor or conduct your own research before making investment decisions.

Sagility India IPO GMP: Expected to list at issue price

Aditya Bhagchandani — Tue, 12 Nov 2024 02:31:15 +0000

Sagility India Ltd., a healthcare services provider, is set to list its equity shares on the BSE and NSE today, November 12. The initial public offering (IPO), which garnered a decent subscription during its bidding period from November 5 to 7, saw an overall subscription of 3.20 times, indicating investor interest. However, with a current grey market premium (GMP) of ₹0, the stock is expected to make a flat debut around its issue price of ₹30 per share.

The IPO was entirely an offer-for-sale (OFS), with the company raising ₹2,106.60 crore through the sale of 70.22 crore equity shares. Financially, Sagility India showed promising growth, with revenue increasing 9.6% to ₹1,223 crore in Q1 FY25 and a 12.69% jump in FY24 to ₹4,753 crore.

Analysts note that recent muted trends in IPO listings could impact Sagility India’s debut, although they remain positive on its growth prospects. Investors who received allotments may consider holding shares for potential medium-term gains. ICICI Securities, IIFL Securities, Jefferies India, and JP Morgan India acted as the IPO’s lead managers, with Link Intime as the registrar.

Sagility India IPO sees 52% subscription on Day 2, weak demand from QIBs

Aditya Bhagchandani — Wed, 06 Nov 2024 12:25:03 +0000

Sagility India Limited’s initial public offering (IPO), which opened for public bidding on November 5, 2024, reached 52% subscription by the end of the second day. The Bengaluru-based healthcare service provider has set the price band at ₹28-₹30 per share, aiming to raise ₹2,106.60 crore through this IPO, structured as an offer-for-sale (OFS) by its Netherlands-based promoter, Sagility BV.

Key Subscription Details:

Total Subscription: 52% of the IPO subscribed on Day 2.
Qualified Institutional Buyers (QIBs): Low demand with only 7% of the reserved quota subscribed.
Non-Institutional Investors (NIIs): Subscribed 24% of their allocated shares.
Retail Individual Investors (RIIs): Higher interest seen with 224% subscription.
Employee Reserved Category: Subscribed at 244%.

Sagility India’s IPO will close on November 7, 2024, and is expected to list on BSE and NSE on November 12, 2024. All proceeds will go to Sagility BV, with Sagility India receiving no funds from this public issue.